Skip to main content

Is the Frequent Urge to Urinate Affecting Your Daily Routine?

Uncomplicated UTI Clinical Trials May Be An Option!

UTIs are frequent infections that occur when bacteria enters the urethra and infects the urinary system, usually through the skin or the rectum. The infections can affect any region of the urinary tract, although bladder infections are the most prevalent type (cystitis).

Urinary tract infections (UTIs) are very common in the U.S. In fact, UTIs are the second most common type of infection in the body. About 10 in 25 women and 3 in 25 men will have symptoms of a UTI during their lifetime.

At Revive Research Institute we understand that all of these symptoms can take a toll on your well-being. We are conducting novel Urinary Tract Infections Clinical Trials in search of a potential treatment for Uncomplicated UTI.

You may be eligible to participate in the UTI Clinical Trials if you:

  • Are a woman above 12 years of age and of a childbearing age
  • Have been diagnosed with an uncomplicated UTI
  • Can comply with study procedures

We are conducting a Phase 3 UTI Clinical Trials for adolescent and adult female participants with the goal of comparing the efficacy and safety of an investigational drug with another drug available in the market.

*If you fulfill the requirement and choose to participate in the UTI Clinical Trials, you will be provided with free study-related care and treatment. Our Urologist, nurses, and research staff will provide each of the participants with study-related care and will monitor your health throughout the duration of your participation in the study. 

*All participants will be monetarily compensated for their time and travel throughout the duration of  their participation in the research study.

Please provide YOUR contact information only.
For more info, please visit Privacy Policy.
Uncomplicated UTI women's health center

About the Uncomplicated UTI Study

Around 2500 women of 12 years or older, who have been diagnosed with urinary tract infection/UTI (Acute Cystitis) will be invited to participate in this 48-month long Urinary Tract Infections Clinical Trials. Your participation, however, will be for almost 28 days.

This is a double-blind, double-dummy study in which two different drugs are being compared to check the level of its effectiveness against this disease. This would mean that you will either receive the study drug or the drug with which this study drug is being compared (Nitrofurantoin) to.

During the 28 days of your study participation, you will be invited to our study site for 4 visits. Out of these 4 visits, 2 will be in the treatment phase where you will be provided with the study drug. The other 2 will be for follow-ups respectively after the treatment has been completed.

We will be comparing the study drug with another drug (Nitrofurantoin) that is approved by the FDA and is readily available in the market. You will be taking these drugs orally with food or water. Evaluation in the Urinary Tract Infections Clinical Research Trials will be based on the healing capacity and efficacy of both drugs.

*Participating in this Clinical Trial does not cost you anything. Instead, it compensates for the time and travel of those eligible. No insurance is required to volunteer in any of our clinical trials.

Get Started: What to Expect?

Urinary Tract Infection (UTI) is inflammation of the urinary tract caused by bacteria. This can affect any part of the tract, most common of which is the UTI of the bladder called Cystitis. Some of the symptoms include frequent urination, burning sensation while urinating, cloudy or reddish coloured and strong-smelling urine. Revive Research Institute is conducting Women’s Health Clinical Trials for uncomplicated UTI. There will be a total of 2500 participants in this study which will be completed over a period of 48 months.

If you think you qualify for the Urinary Tract Infections Clinical Research Trials, please fill the form above. After this, someone from our research staff will contact you to determine whether you’re a suitable fit for our Uncomplicated UTI Clinical Trials. You will be requested to sign an Informed Consent Form (ICF) after your eligibility has been confirmed. Once it’s signed, several study-related questions will be asked, after which you would be asked to go through certain assessments. Study treatment is given after you have qualified as a participant.

Length of study Treatment

28 Days

Number of study visits

4 Visits

Long term follow up


About Urinary Tract Infections

Uncomplicated UTI clinical trials

A Urinary Tract Infection (UTI) may affect any component of your urinary system, including the kidneys, ureters, bladder, and urethra. The bladder and urethra are the most commonly infected parts of the urinary tract.

UTI occurs when the body is unable to flush out bacteria before it reaches the bladder, through urination. The bacteria commonly involved in UTIs are escherichia coli, proteus mirabilis, enterococcus faecalis, staphylococcus saprophyticus, and klebsiella pneumoniae. Some cases of UTIs may also be caused by fungi and in rare cases by viruses.


The symptoms of a urinary tract infection vary depending on which segment of the urinary system is affected. Some common symptoms include burning with urination, increased frequency and urgency of urination, bloody or cloudy urine, strong odor of urine, nausea, fever, chills, vomiting and pelvic pain (in women) or rectal pain (in men).

Risk Factors:

A UTI can affect people of any age or gender. However, women are more likely than men to get a urinary tract infection. Other factors that make people more susceptible to UTI includes people who are sexually active, having diabetes or previous UTIs, kidney stones, using catheter for a long time and poor hygiene.

Prevention or Management:

A person can take a number of steps to lower their chances of acquiring a UTI by drinking 6–8, 8-ounce glasses of water per day, urinating after sex, emptying the bladder completely and keeping your genitals clean.


A bladder infection can be both painful and inconvenient but if it spreads through the kidneys, it might have significant implications. It is important to treat UTIs earlier. Untreated UTIs can become more and more severe, sometimes leading to the infection entering the blood circulation which results in sepsis.

Frequently Asked Questions (FAQs)

1. Why is UTI more common in women than in men?

The female urethra is shorter in length as compared to the male urethra. This length in urethra along with the antibacterial prostatic-fluid protects the males against this infection.

2. What will happen if a UTI is left untreated?

If left untreated, UTI can cause multiple complications. It can ascend to the kidneys through your urethra causing their damage. This can lead to permanent reduction in kidney function or even kidney failure.

3. Does blood in urine mean I have UTI?

Normally blood is not present in urine. Passing dark or red colored urine might be indicative of injury to the urethra, urinary tract infection or the presence of kidney stones. If you find blood in the urine it warrants seeking immediate medical attention for further tests.

4. Are there benefits to my child participating in a clinical study?

Study participation offers several potential benefits:

  • You play an active role in your child’s healthcare.
  • Your child may gain access to new treatments not yet available to the public.
  • Your child will have expert medical care at a leading healthcare facility.
  • Everyone in a clinical study contributes in some fashion to medical knowledge that will benefit others.

5. Can kids be a part of Clinical Trials?

Because your child is a minor, you may be legally required to give informed consent allowing them to participate. Your child may also need to give their assent after having the trial explained to them in an age-appropriate manner.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI

T: 248-564-1485